Diagnosis, management, and treatment of hepatitis C: an update - PubMed (original) (raw)

Practice Guideline

. 2009 Apr;49(4):1335-74.

doi: 10.1002/hep.22759.

Collaborators, Affiliations

Practice Guideline

Diagnosis, management, and treatment of hepatitis C: an update

Marc G Ghany et al. Hepatology. 2009 Apr.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

Graphic display of virological responses. RVR, rapid virological response (clearance of HCV from serum by week 4 using a sensitive PCR-based assay); EVR, early virological response (≥2 log reduction in HCV RNA level compared to baseline HCV RNA level or HCV RNA negative at treatment week 12); SVR, sustained virological response (HCV RNA negative 24 weeks after cessation of treatment); relapse, reappearance of HCV RNA in serum after therapy is discontinued; nonresponder, failure to clear HCV RNA from serum after 24 weeks of therapy; partial nonresponder, 2 log decrease in HCV RNA but still HCV RNA positive at week 24; null nonresponder, failure to decrease HCV RNA by < 2 logs after 24 week of therapy.

Figure 2

Figure 2

Virological responses to pegylated interferon and ribavirin in the two U.S. Registration trials., ETR, end-of-treatment response; SVR, sustained virological response.

Figure 3

Figure 3

Treatment algorithm for managing and treating patients with chronic HCV infection, genotype 1. SVR, sustained virologic response; EVR, early virologic response. RVR is omitted from this treatment algorithm because it has not yet been adequately evaluated. HCV RNA should be quantitated using a sensitive assay (10–50 IU/mL).

Figure 4

Figure 4

Treatment algorithm for managing and treating patients with chronic HCV infection, genotype 2 or 3. EVR, early virologic response; ETR, end of treatment response; SVR, sustained virologic response. RVR is omitted from this treatment algorithm because it has not yet been adequately evaluated. HCV RNA should be quantitated using a sensitive assay (10–50 IU/mL).

Comment in

References

    1. Eddy D A manual for assessing health practices and designing practice guidelines. Philadelphia: American College of Physicians; 1996: 1– 126.
    1. American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. Gastroenterology 1995; 108: 925– 926. - PubMed
    1. http://www.heart.org/presenter.jhtml?identifier=3039683 MMfAApAaa.
    1. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139: 493– 498. - PubMed
    1. Williams R Global challenges in liver disease. HEPATOLOGY 2006; 44: 521– 526. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources